Costs of smoking-attributable productivity losses in Poland.

Adv Exp Med Biol

Institute of Econometrics, The Collegium of Economic Analysis, Warsaw School of Economics, Warsaw, Poland.

Published: November 2012

In Poland smoking poses a severe socioeconomic problem. Not only does tobacco consumption cause an increase in direct medical costs due to the necessity for treatment of smoking-attributable diseases, but it also generates indirect costs due to productivity losses. The aim of this paper was to estimate the annual productivity loss due to smoking in Poland from the societal perspective and to compare the obtained results with the equivalent research in other selected countries (Germany, Sweden, and USA). The assessment was performed by the use of the human capital approach, considering loss of productivity until achieving the retirement age and gross income. Four distinct components of indirect costs of nicotine consumption were included: costs of premature mortality, costs of acquired disability, as well as costs of absenteeism and presenteeism caused by smokers. The costs of smoking-attributable productivity loss within a year amount to more than 15 billion PLN (1 Euro approx. 4 PLN) which is about 402 PLN per capita and 1418 PLN per smoker. This represents about 2.6% of Polish annual Gross Domestic Product (GDP), which is more than in Germany, Sweden, or the USA. This amount clearly shows the enormous socioeconomic burden and suggests the need for taking measures to reduce it.

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-94-007-4546-9_23DOI Listing

Publication Analysis

Top Keywords

costs
8
costs smoking-attributable
8
smoking-attributable productivity
8
productivity losses
8
indirect costs
8
productivity loss
8
germany sweden
8
sweden usa
8
productivity
5
losses poland
4

Similar Publications

Background: Substantial out-of-pocket (OOP) expenditures push a large portion of the population below the poverty line, especially those residing in rural areas having low incomes. Individuals from economically disadvantaged states in India incur higher healthcare costs for hospitalization in public health centers than do those from more developed states. Economically poorer households in states such as Bihar and Odisha face significantly higher OOP expenditures for hospitalization in public health centers than do those in economically developed states such as Tamil Nadu.

View Article and Find Full Text PDF

Methodological considerations for estimating indirect costs in children and adolescents with chronic conditions: a scoping review.

BMC Pediatr

January 2025

Chair for Institutional Economics and Health Policy, Department of Philosophy, Politics and Economics, Witten/Herdecke University, Witten, Germany.

Background: In children and adolescents, the prevalence of chronic diseases, e.g., obesity, asthma, and attention-deficit/hyperactivity disorder (ADHD), has increased in the last decades.

View Article and Find Full Text PDF

Background: People with malignancy of undefined primary origin (MUO) have a poor prognosis and may undergo a protracted diagnostic workup causing patient distress and high cancer related costs. Not having a primary diagnosis limits timely site-specific treatment and access to precision medicine. There is a need to improve the diagnostic process, and healthcare delivery and support for these patients.

View Article and Find Full Text PDF

Global regional and national burden of intracerebral hemorrhage between 1990 and 2021.

Sci Rep

January 2025

Department of Vascular Surgery, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.

Intracerebral hemorrhage (ICH) represents one of the most devastating forms of stroke, characterized by spontaneous bleeding into the brain parenchyma. This neurological emergency carries a substantial burden of mortality and long-term disability worldwide. A comprehensive understanding of ICH's evolving global impact from 1990 to 2021 remains essential for healthcare planning and resource allocation.

View Article and Find Full Text PDF

Blood transfusion plays a vital role in modern medicine, but frequent shortages occur. Ex vivo manufacturing of red blood cells (RBCs) from universal donor cells offers a potential solution, yet the high cost of recombinant cytokines remains a barrier. Erythropoietin (EPO) signaling is crucial for RBC development, and EPO is among the most expensive media components.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!